China’s Hengrui seals US$15.2 billion deal with US pharmaceutical giant BMS
- Posted on May 12, 2026
- By South China Morning Post
- 1 Views
- 1 min read
China’s Hengrui seals US$15.2 billion deal with US pharmaceutical giant BMS
Company’s shares jump in Hong Kong and Shenzhen after tie-up that bolsters China’s growing drug innovation profile.
